Objective Multiple sclerosis (MS) is associated with cognitive impairment (CI) such as
slowed information processing speed (IPS). Currently, no immunocellular or molecular …

Nowadays, there is a need for reliable fluid biomarkers to improve differential diagnosis,
prognosis, and the prediction of treatment response, particularly in the management of …

The clinical course of multiple sclerosis (MS) is highly variable among patients, thus creating
important challenges for the neurologist to appropriately treat and monitor patient progress …

Background Cognitive impairment frequently affects people with multiple sclerosis (MS).
Low vitamin D has been associated with cognitive dysfunction in different …

We conducted a retrospective analysis on multiple sclerosis (MS) patients with perceived
cognitive decline and long disease duration to investigate early predictors of future cognitive …

Background: Multiple sclerosis (MS) is a chronic immune-mediated central nervous system
disorder that affects females twice as often as males. MS patients show increased …

Aim: The present study was conducted to assess the impact of gene (vitamin D receptor
[VDR] polymorphisms)–environment (serum vitamin D and calcium levels) interaction on …

Cognitive Impairment (CI) is one of the most common and devastating manifestations in
patients with Multiple Sclerosis (MS), which directly impacts the quality of life (QOL) and …

Cognitive impairment is one of the most significant burdens among the many neurological
complaints in multiple sclerosis patients. Cognitive deficits negatively impact these patients' …

Cognitive impairment (CI) is common in amyotrophic lateral sclerosis (ALS): a keystone is
identifying factors that could potentially modify the CI course. In recent years, vitamin D is …